These medications help regulate blood sugar levels and promote weight loss by enhancing insulin secretion and reducing appetite
This initial loss often reflects decreased appetite, reduced calorie intake, and improved blood sugar control
Between 2012 and 2016, the guideline for DSIP spending was: 30 percent for infrastructure, 20 percent for health service improvement, 20 percent for education, 10 percent for law and order, 10 percent for economic support, and 10 percent for administration
Clinical trials reveal weight loss averaging 15 to 20 percent of body weight when combined with lifestyle alterations, making it one of the most potent weight loss medications available
Ozempic and Wegovy are both GLP-1 injections that contain the active ingredient semaglutide